Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,178 | -57,358 | -34,197 | -15,204 | -74,163 |
| Depreciation Amortization | 350 | 256 | 163 | 76 | 319 |
| Accounts receivable | 373 | 1,086 | 246 | -300 | -308 |
| Other Working Capital | 16,381 | 2,256 | 2,304 | -2,487 | -227 |
| Other Operating Activity | 4,680 | 2,612 | 2,123 | 1,273 | 5,715 |
| Operating Cash Flow | $-73,394 | $-51,148 | $-29,361 | $-16,642 | $-68,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,013 | -34,061 | -16,048 | -8,000 | -39,000 |
| PPE Investments | -1,018 | -837 | -454 | -138 | -557 |
| Purchase Of Investment | -18,951 | -13,940 | N/A | N/A | -38,652 |
| Sale Of Investment | 87,851 | 84,673 | 57,014 | 15,877 | 66,454 |
| Investing Cash Flow | $41,869 | $35,835 | $40,512 | $7,739 | $-11,755 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 33,903 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 14,079 | 13,758 | 18 | 16 | 92,374 |
| Other Financing Activity | -32 | 14,196 | 0 | 0 | 0 |
| Financing Cash Flow | $47,950 | $27,954 | $18 | $16 | $92,374 |
| Exchange Rate Effect | 41 | 25 | 48 | 13 | -43 |
| Beginning Cash Position | 28,118 | 28,118 | 28,118 | 28,118 | 16,206 |
| End Cash Position | 44,584 | 40,784 | 39,335 | 19,244 | 28,118 |
| Net Cash Flow | $16,466 | $12,666 | $11,217 | $-8,874 | $11,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,394 | -51,148 | -29,361 | -16,642 | -68,664 |
| Capital Expenditure | -1,058 | -861 | -454 | -138 | -567 |
| Free Cash Flow | -74,452 | -52,009 | -29,815 | -16,780 | -69,231 |